Cryptogenic organizing pneumonia due to amiodarone: long-term follow-up after corticosteroid treatmentKryptogene organisierende Pneumonie nach Amiodaron-Behandlung: Langzeitverlauf nach Corticosteroidbehandlung

被引:0
作者
Katja Schindler
Wolfgang Schima
Josef F. Kaliman
机构
[1] KH Göttlicher Heiland,Abteilung für Innere Medizin 1
[2] KH Göttlicher Heiland,Abteilung für Radiologie und bildgebende Diagnostik
来源
Wiener klinische Wochenschrift | 2010年 / 122卷
关键词
Amiodarone; Cryptogenic organizing pneumonia; Toxicity; HRCT; Interstitial lung disease;
D O I
暂无
中图分类号
学科分类号
摘要
Cryptogenic organizing pneumonia (formerly known as bronchiolitis obliterans organizing pneumonia) is a clinicopathological entity with characteristical radiographic findings such as bilateral, asymmetrical, sometimes migrating, patchy infiltrates in chest radiograph and ground-glass opacities in computed tomography. The disease has been observed in the context of gastrointestinal disorders, certain lung infections, autoimmune-mediated diseases (such as Wegener granulomatosis), inhalation of toxic fumes, bone marrow transplantation and administration of drugs. The benzofuran amiodarone, a commonly used antiarrythmic drug for atrial fibrillation, can exhibit several pulmonary adverse effects, amongst them cryptogenic organizing pneumonia as a rarely diagnosed and published one. We report a case of cryptogenic organizing pneumonia secondary to amiodarone treatment, its clinical course with significant improvement of clinical symptoms within a few days after discontinuation of amiodarone treatment and administration of corticosteroids. Also the infiltrations found in chest X-ray and computed tomography responded well and showed remarkable resolution tendency quickly. During 5 months of corticoid therapy pulmonary abnormalities gradually resolved almost completely and remained equal during the 8 months follow-up after corticoid termination.
引用
收藏
页码:511 / 514
页数:3
相关论文
共 117 条
  • [21] Cordier JF(2008)A patient with relapsing pneumonia Respir Med CME 1 250-252
  • [22] Afessa B(2000)Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance Can J Cardiol 16 1435-1440
  • [23] Litzow MR(1995)Bronchiolitis obliterans with organising pneumonia: outcome Thorax 50 59-64
  • [24] Tefferi A(1990)Amiodarone pulmonary toxicity: CT findings in symptomatic patients Radiology 177 121-125
  • [25] Garrido M(2005)Detection of amiodarone-induced pulmonary toxicity in supine and prone positions: high-resolution computed tomography study Circ J 69 466-470
  • [26] O'Brien A(1992)Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis Chest 102 999-1004
  • [27] González S(2003)Pulmonary toxicity in patients receiving low-dose amiodarone Chest 123 646-651
  • [28] Clavero JM(2006)Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: cytologic, histologic, and electronmicroscopic findings Diagn Cytopathol 34 351-354
  • [29] Orellana E(1991)Amiodarone-related postoperative adult respiratory distress syndrome Circulation 84 407-415
  • [30] Biehn SE(undefined)undefined undefined undefined undefined-undefined